Albemarle (NYSE: ALB) reported Q3 EPS of $7.50, $0.72 better than the analyst estimate of $6.78. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.2 billion.

GUIDANCE:

Albemarle sees FY2022 EPS of $19.75-$21.75, versus the consensus of $21.28. Albemarle sees FY2022 revenue of $7.1-7.4 billion, versus the consensus of $7.51 billion.

For earnings history and earnings-related data on Albemarle (ALB) click here.